Cohen Klingenstein LLC Abbott Laboratories Transaction History
Cohen Klingenstein LLC
- $3.07 Billion
- Q3 2025
A detailed history of Cohen Klingenstein LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cohen Klingenstein LLC holds 49,435 shares of ABT stock, worth $6.3 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
49,435
Previous 49,435
-0.0%
Holding current value
$6.3 Million
Previous $6.72 Million
1.52%
% of portfolio
0.22%
Previous 0.23%
Shares
6 transactions
Others Institutions Holding ABT
# of Institutions
3,606Shares Held
1.4BCall Options Held
9.23MPut Options Held
8.1M-
Vanguard Group Inc Valley Forge, PA173MShares$22 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$9.99 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.67 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.33 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $223B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...